Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 218.41 per share at the end of the most recent trading day (a 1.75% change compared to the prior day closing price) with a volume of 702.84K shares and market capitalization of 19.33B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72400 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is -20.92%, while year-to-date (YTD) performance is -7.25%. LH stock has a five-year performance of 34.41%. Its 52-week range is between 200.32 and 280.7181, which gives LH stock a 52-week price range ratio of 22.50%

Laboratory Corporation of America Holdings currently has a PE ratio of 13.00, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 1.93, a price to cashflow ratio of 11.30, a PEG ratio of 2.32, a ROA of 9.36%, a ROC of 11.40% and a ROE of 18.48%. The company’s profit margin is 10.75%, its EBITDA margin is 20.10%, and its revenue ttm is $11.20 Billion , which makes it $126.44 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $3.99 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 27th Apr 2023.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.54), with a target price of $267.5, which is +22.48% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of 1.18% with a dividend per share of $2.88 and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Sell technical analysis rating based on Technical Indicators (ADX : 17.66, ATR14 : 5.46, CCI20 : -77.40, Chaikin Money Flow : -0.07, MACD : -7.12, Money Flow Index : 26.02, ROC : -5.02, RSI : 37.90, STOCH (14,3) : 24.58, STOCH RSI : 1.00, UO : 48.32, Williams %R : -75.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Amy B. Summy (Option Excercise at a value of $0), Brian J. Caveney (Buy at a value of $40 852), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $4 722 543), Glenn A. Eisenberg (Sold 57 100 shares of value $13 417 023 ), Jean-Luc Belingard (Option Excercise at a value of $0), Jeffrey A. Davis (Option Excercise at a value of $0), Judith C. Seltz (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $0), Kerrii B. Anderson (Option Excercise at a value of $0), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 4 514 shares of value $1 170 703 ), Paul Kirchgraber (Option Excercise at a value of $547 530), Paul Kirchgraber (Sold 8 000 shares of value $2 004 675 ), Peter J. Wilkinson (Option Excercise at a value of $112 435), Peter J. Wilkinson (Sold 2 576 shares of value $665 635 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $0), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 2 841 shares of value $775 786 )